Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
Company Reports 50% Increase in Revenue 3SBio...
Last week, Regenerx was awarded a patent in China for its...
For a change, a China-based biopharma released a Q3...
It was another significant week for investments in China...
China's economy made an indelible impression on the world...
The ChinaBio® Stock Index, comprised of 17...
3SBio Inc. reported fourth quarter financial results that...
QIAGEN (NSDQ: QGEN) established an Asia-Pacific Service...
3SBio Inc. (NSDQ: SSRX) announced that...
Last week, against the backdrop of the heparin scandal,...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
